Both in Biotechnology
Amgen vs Moderna
Over the past year AMGN returned +52.6% and MRNA returned +678.8%; their daily moves had a correlation of 0.26.
AMGN +52.6% MRNA +678.8%Growth of $1, one year, split-adjusted
| Metric | AMGN | MRNA |
|---|---|---|
| Price | $418.13 | $197.28 |
| Market cap | $226.05B | $78.76B |
| Today | +0.85% | −0.80% |
| 1 month | −4.3% | +38.2% |
| 6 months | +19.9% | +298.1% |
| Year to date | +27.7% | +569.0% |
| 1 year | +54.2% | +701.6% |
| Revenue growth (YoY) | +9.5% | +2.1% |
| Gross margin | 72.0% | 35.9% |
| Net margin | 23.6% | −539.3% |
| P/E (TTM) | 25.9× | — |
| Price / sales | 5.9× | 35.4× |
| Net cash | -$43.31B | $4.54B |
| Dividend yield | 2.41% | — |
| Volatility (60d) | 34.0% | 227.6% |
| Short % of float | 2.6% | 9.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).